SAN ANTONIO, Dec. 10, 2024 /PRNewswire/ -- The START Center for Cancer ... Sarepta, Biotech's Regulatory Go-Getter, Signs Standout Rare Disease Deal.
News
- The START Center for Cancer Research Expands its Capabilities to Support Early-Phase ...
- SystImmune, Inc. to Present Updated BL-B01D1 Data in Breast Cancer at SABCS Congress 2024
(SystImmune), a clinical-stage biotechnology company, today announced ... San Antonio Breast Cancer Symposium (SABCS) 2024, taking place on ...
- Wobble Genomics' technology demonstrates potential in accelerating precision medicine innovations
Wobble Genomics, a healthcare and biotechnology company at the forefront of long-read RNA sequencing, has presented new data at the San Antonio ...
- San Antonio: An Urban Planner's Guide to the City | Planetizen
San Antonio Texas Riverwalk at christmas nighttime. The Riverwalk in ... This has contributed greatly to innovation in the bioscience ...
- Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer ...
... San Antonio Breast Cancer Symposium, held December 10-13 in San Antonio ... Monte Rosa Therapeutics is a clinical-stage biotechnology company ...